Literature DB >> 33144412

Telomere Length and Hematological Disorders: A Review.

Beatriz Maria Dias Nogueira1, Caio Bezerra Machado1, Raquel Carvalho Montenegro1, Maria Elisabete Amaral DE Moraes1, Caroline Aquino Moreira-Nunes2.   

Abstract

Telomeres compose the end portions of human chromosomes, and their main function is to protect the genome. In hematological disorders, telomeres are shortened, predisposing to genetic instability that may cause DNA damage and chromosomal rearrangements, inducing a poor clinical outcome. Studies from 2010 to 2019 were compiled and experimental studies using samples of patients diagnosed with hematological malignancies that reported the size of the telomeres were described. Abnormal telomere shortening is described in cancer, but in hematological neoplasms, telomeres are still shortened even after telomerase reactivation. In this study, we compared the sizes of telomeres in leukemias, myelodysplastic syndrome and lymphomas, identifying that the smallest telomeres are present in patients at relapse. In conclusion, the experimental and clinical data analyzed in this review demonstrate that excessive telomere shortening is present in major hematological malignancies and its analysis and measurement is a crucial step in determining patient prognosis, predicting disease risk and assisting in the decision for targeted therapeutic strategies. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Telomere length; cancer; hematological disorders; review

Mesh:

Substances:

Year:  2020        PMID: 33144412      PMCID: PMC7811674          DOI: 10.21873/invivo.12142

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  64 in total

1.  In the end, what's the problem?

Authors:  Raymund J Wellinger
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

Review 2.  Telomere biology in hematopoiesis and stem cell transplantation.

Authors:  Shahinaz M Gadalla; Sharon A Savage
Journal:  Blood Rev       Date:  2011-07-20       Impact factor: 8.250

3.  Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.

Authors:  Anne-Sophie Bouillon; Monica S Ventura Ferreira; Shady Adnan Awad; Johan Richter; Andreas Hochhaus; Volker Kunzmann; Jolanta Dengler; Jeroen Janssen; Gert Ossenkoppele; Peter E Westerweel; Peter A W Te Boekhorst; Francois-Xavier Mahon; Henrik Hjorth-Hansen; Susanne Isfort; Thoas Fioretos; Sebastian Hummel; Mirle Schemionek; Stefan Wilop; Steffen Koschmieder; Susanne Saußele; Satu Mustjoki; Fabian Beier; Tim H Brümmendorf
Journal:  Blood Adv       Date:  2018-07-10

Review 4.  Biological and clinical implications of telomere dysfunction in myeloid malignancies.

Authors:  Ashwin Kishtagari; Justin Watts
Journal:  Ther Adv Hematol       Date:  2017-10-06

Review 5.  Telomere dysfunction and its role in haematological cancer.

Authors:  Ceri H Jones; Chris Pepper; Duncan M Baird
Journal:  Br J Haematol       Date:  2012-01-11       Impact factor: 6.998

6.  Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.

Authors:  Billy Michael Chelliah Jebaraj; Eugen Tausch; Dan A Landau; Jasmin Bahlo; Sandra Robrecht; Amaro N Taylor-Weiner; Johannes Bloehdorn; Annika Scheffold; Daniel Mertens; Sebastian Böttcher; Michael Kneba; Ulrich Jäger; Thorsten Zenz; Michael K Wenger; Guenter Fingerle-Rowson; Clemens Wendtner; Anna-Maria Fink; Catherine J Wu; Barbara Eichhorst; Kirsten Fischer; Michael Hallek; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Leukemia       Date:  2019-03-25       Impact factor: 11.528

7.  DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Authors:  Donghyun D Lee; Ricardo Leão; Martin Komosa; Marco Gallo; Cindy H Zhang; Tatiana Lipman; Marc Remke; Abolfazl Heidari; Nuno Miguel Nunes; Joana D Apolónio; Aryeh J Price; Ramon Andrade De Mello; João S Dias; David Huntsman; Thomas Hermanns; Peter J Wild; Robert Vanner; Gelareh Zadeh; Jason Karamchandani; Sunit Das; Michael D Taylor; Cynthia E Hawkins; Jonathan D Wasserman; Arnaldo Figueiredo; Robert J Hamilton; Mark D Minden; Khalida Wani; Bill Diplas; Hai Yan; Kenneth Aldape; Mohammad R Akbari; Arnavaz Danesh; Trevor J Pugh; Peter B Dirks; Pedro Castelo-Branco; Uri Tabori
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

Review 8.  Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.

Authors:  Christine J Harrison
Journal:  Br J Haematol       Date:  2008-11-01       Impact factor: 6.998

Review 9.  Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.

Authors:  Maria M Gramatges; Alison A Bertuch
Journal:  Transl Res       Date:  2013-06-01       Impact factor: 10.171

Review 10.  Regulation of human telomerase in homeostasis and disease.

Authors:  Caitlin M Roake; Steven E Artandi
Journal:  Nat Rev Mol Cell Biol       Date:  2020-04-02       Impact factor: 113.915

View more
  5 in total

Review 1.  Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges.

Authors:  Dimitrios Tsilingiris; Narjes Nasiri-Ansari; Nikolaos Spyrou; Faidon Magkos; Maria Dalamaga
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

2.  Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.

Authors:  Beatriz Maria Dias Nogueira; Laudreísa da Costa Pantoja; Emerson Lucena da Silva; Fernando Augusto Rodrigues Mello Júnior; Eliel Barbosa Teixeira; Alayde Vieira Wanderley; Jersey Heitor da Silva Maués; Manoel Odorico de Moraes Filho; Maria Elisabete Amaral de Moraes; Raquel Carvalho Montenegro; André Salim Khayat; Caroline Aquino Moreira-Nunes
Journal:  Genes (Basel)       Date:  2021-10-17       Impact factor: 4.096

3.  TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia.

Authors:  Marta Dratwa; Barbara Wysoczańska; Aleksandra Butrym; Piotr Łacina; Grzegorz Mazur; Katarzyna Bogunia-Kubik
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

4.  Transcriptomic Analysis of Conserved Telomere Maintenance Component 1 (CTC1) and Its Association with Leukemia.

Authors:  Saadiya Zia; Netasha Khan; Komal Tehreem; Nazia Rehman; Rokayya Sami; Roua S Baty; Faris J Tayeb; Majed N Almashjary; Nouf H Alsubhi; Ghadeer I Alrefaei; Ramla Shahid
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

5.  Methylation of Subtelomeric Chromatin Modifies the Expression of the lncRNA TERRA, Disturbing Telomere Homeostasis.

Authors:  Diego Oliva-Rico; Eunice Fabian-Morales; Rodrigo E Cáceres-Gutiérrez; Adriana Gudiño; Fernanda Cisneros-Soberanis; Julieta Dominguez; Oscar Almaraz-Rojas; Cristian Arriaga-Canon; Clementina Castro-Hernández; Carlos De la Rosa; José L Reyes; Luis A Herrera
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.